TMTrey McGonigle

Trey McGonigle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Trey McGonigle has a total of 145 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Influenza Vaccination and Symptom Burden in Ambulatory Patients With Confirmed Influenza: Evidence From Case-ascertained Household Transmission Studies

    by Amanda C Howa, Yuwei Zhu, Trey McGonigle, Huong Q Nguyen, Melissa S Stockwell, Yvonne Maldonado, Karen Lutrick, Natalie M Bowman, Suchitra Rao, Jonathan Schmitz, et al.

    Background: The extent to which influenza vaccination may temper disease remains uncertain. We compared symptoms between influenza vaccinated and unvaccinated ambulatory persons with influenza. Methods: We conducted household transmission studies across multiple US sites during consecutive influenza seasons from 2017–2018 through 2022–2023 (excluding 2020–2021 season with minimal influenza activity). We collected daily symptom diaries and respiratory specimens. Three scores were calculated, varying weights on specific symptoms: (1) influenza-like illness (ILI); (2) lower respiratory; and (3) all symptoms. For each score, we examined the daily mean score between those vaccinated and unvaccinated against influenza using weighted multivariable linear mixed effects and frailty models. Results: The study included 869 children (41% vaccinated, 47% female, 58% White, non-Hispanic) and 653 adults (42% vaccinated, 65% female, 72% White, non-Hispanic) with laboratory-confirmed influenza. In multivariable analyses, the mean difference in the daily ILI score was −0.16 (95% CI, −.32 to −.01) between vaccinated and unvaccinated children and −0.18 (95% CI, −.34 to −.01) for the lower respiratory score. There was no significant difference among adults. Influenza vaccination was not associated with time to symptom alleviation among children. However, ILI symptom alleviation occurred earlier among vaccinated (HR: 1.30; 95% CI, 1.04–1.62) adults. Conclusions: Ambulatory children with influenza who were vaccinated experienced less ILI symptom burden compared to those who were not vaccinated against influenza, but vaccination was not associated with symptom duration. Conversely, among ambulatory adults with influenza, vaccination and symptom burden were not associated, but vaccination was associated with faster alleviation of ILI symptoms.

  • Open Access

    Study protocol and statistical analysis plan for a randomized, double-blind, controlled trial evaluating recombinant human platelet-derived growth factor B (rhPDGF) in the reconstruction of complex head or neck defects following skin cancer excision

    by Cyndi R Clark, Bryan S Blette, Ricardo A Torres Guzman, Melissa D Lempicki, Georgios Karamitros, Franklin Gergoudis, Barite W Gutama, Daniel R O’NEill, Benjamin Savitz, Jacob Smith, et al.

    Background: Phenome-wide association studies (PheWAS) can reveal novel associations between variants in drug-target genes and disease and, as such, can be used to predict new drug-indication pairs for repurposing drugs with a known mechanism of action. A platelet-derived growth factor receptor beta (PDGFRβ) PheWAS demonstrated that patients with a single nucleotide variant that reduces PDGFRβ expression exhibit a higher prevalence of chronic skin ulcers, skin grafts, and reconstructive surgeries. Recombinant human platelet derived growth factor BB (rhPDGF) is a therapeutic that binds to and activates PDGFRβ and has received FDA approval for multiple indications, including improving healing of lower extremity diabetic neuropathic ulcers, augmenting periodontal bone and soft tissue reconstruction, and stimulating orthopedic bone regeneration. Leveraging a drug-repurposing methodology informed by PheWAS, we hypothesize that rhPDGF will provide therapeutic benefit in the treatment of other complex wounds, like full-thickness surgical wounds of the head or neck that cannot heal by primary intention following skin cancer excision. Methods: This prospective, double-blinded, single-site study aims to enroll 40 participants, randomized at a ratio of 1:1, comparing the efficacy of an advanced wound matrix saturated with rhPDGF or saline. Comparisons will be stratified by anatomical location (scalp/forehead versus face/neck) and maximum surgical defect dimensions ( < 3cm versus > 3cm). The primary outcome of this study will evaluate the time in days to 81-100% granulation of the wound bed by expert clinical assessment of daily photographs. Secondary outcomes will assess the superiority of the rhPDGF-enhanced wound matrix relative to control with respect to wound granulation rate, epithelialization, complete wound healing, and patient reported outcomes (PROMs). Discussion: Although reconstructive techniques are available for healing complex head and neck wounds following skin cancer excision, these procedures are invasive, and older, frail patients are often suboptimal candidates. There remains a need for less invasive therapeutic approaches that reduce the healing time and mitigate the morbidity associated with chronic wounds. A PheWAS analysis identified complex wounds requiring reconstructive surgery as a novel drug-indication pair for repurposing rhPDGF. This protocol is designed to evaluate the efficacy of an rhPDGF-enhanced advanced wound matrix for healing complex head and neck wounds post skin cancer excision that cannot heal by primary intention. Clinical trial registration: This trial is registered at ClinicalTrials.gov ( NCT06634030 ).

  • Open Access

    Adverse Childhood Experiences in Autistic and Neurotypical Girls

    by Jon Ebert, Rachael A. Muscatello, Trey McGonigle, Simon Vandekar, Blythe A. Corbett

    Adverse childhood experiences (ACEs) are potentially traumatic, life‐altering events that occur in childhood with long‐term negative physical and/or mental health outcomes. Previous research, while limited and largely focused on males, suggests children with autism spectrum disorder (ASD) are at higher risk of experiencing ACEs than typically developing (TD) peers. The study aimed to enhance our understanding of ACEs by focusing on female participants comparing diagnostic (ASD, TD), developmental (age, puberty), and mental health (anxiety, depression) factors. Participants included 212 female children with ASD ( N = 112) or TD ( N = 100) between 6:0 to 12:11 years. Following diagnostic testing, the 10‐item ACEs questionnaire was administered. Statistical analyses included Wilcoxon rank‐sum tests, negative‐binomial models, linear regression, and Spearman correlations. There was a significant group difference in the total number of ACEs such that autistic children had more parent‐reported total adverse events ( p = 0.024). There were no significant diagnosis by age or puberty stage interactions ( p > 0.05). Depressive symptoms were significantly positively associated with autism diagnosis ( p < 0.001, RESI = 0.574) and ACE total ( p < 0.001, RESI = 0.282), indicating overall higher rates of depressive symptoms in autistic youth, and an increase in depressive symptoms for participants with at least one ACE. There were similar findings for anxiety. Results highlight that having autism along with ACEs may place youth at a higher risk of mental health conditions. Treatments developed to address the unique challenges of adverse events in autism may be warranted to prevent long‐term sequelae and poor mental health outcomes.

  • Open Access

    Investigating a biopsychosocial model of depression in autistic youth: The intersection of cortisol and depressive symptoms

    by Blythe A. Corbett, Trey McGonigle, Nneka Ijeli, Simon Vandekar, Rachael A. Muscatello, Sloane Sparks

  • Open Access

    Exploring trajectories of anxiety symptoms in autistic and non-autistic youth over adolescence using parent- and self-report measures

    by Meredith Cola, Rachael A. Muscatello, Xinyu Zhang, Simon Vandekar, Trey McGonigle, Blythe A. Corbett

  • Open Access

    Examining androgen and estrogen profiles during pubertal development in autistic and neurotypical girls

    by Blythe A. Corbett, Rachel Calvosa, Jaclyn Tamaroff, Rachael A. Muscatello, Trey McGonigle, Simon Vandekar


  • Characterizing the Relationship Among the Social Competence Elements in Autistic Adolescents

    by Alexandra P. Key, Trey McGonigle, Jinyuan Liu, Rachael Muscatello, Philip Gable, Susan White, Matthew Lerner, Blythe A. Corbett

    Individuals with autism spectrum disorder have significant difficulties in social competence. This study provided empirical evaluation of the theoretical model by Kennedy and Adolphs (2012) positing that social competence relies on an interconnected network of four components: social brain, cognition, behavior, and functioning. Data from 243 youth (69 female, 174 male), age 10–17 years, were used to test the hypothesized mediation effect of social cognition (Theory of Mind) from social brain (event‐related potential markers of face perception and memory) to social behavior (Contextual Assessment of Social Skills) and functioning (Child Behavior Checklist). An additional analysis evaluated whether the structure of the social competence model varied based on the biological sex of the autistic participants. The findings support the conceptual model of social competence where the social brain's contributions to social behavior and functioning are mediated by social cognition, with an additional direct path between the brain and behavior. The relationship among the four components of social competence is not significantly different for autistic males and females. Social competence is best represented as a network of direct and indirect connections among the neural, cognitive, and behavioral components. Thus, focusing on any single element is not sufficient for effective design of novel assessment and treatment approaches in autism. The findings also highlight the importance of self‐initiated active engagement with social cues as a contributor to successful social behavior and functioning in autism.


  • Open Access

    Trajectory of sleep patterns across adolescence in autistic and neurotypical youth

    by Beth A. Malow, Rachael A. Muscatello, Trey McGonigle, Simon Vandekar, Blythe A. Corbett


  • Open Access

    Exploring the Trajectory of Catatonia in Neurodiverse and Neurotypical Pediatric Hospitalizations: A Multicenter Longitudinal Analysis

    by James Luccarelli, Jacqueline A. Clauss, Tasia York, Isaac Baldwin, Simon Vandekar, Trey McGonigle, Gregory Fricchione, Catherine Fuchs, Joshua R. Smith

    Objective: Catatonia is a neuropsychiatric disorder that occurs in pediatric patients with a range of associated medical, psychiatric, and neurodevelopmental disorders (NDDs). This study describes hospital care of pediatric catatonia patients and compares treatments for neurotypical patients and those with NDDs. Methods: Retrospective cohort study from 1/1/2018 to 6/1/2023 of two academic medical centers of patients aged 18 and younger with catatonia. Patients were retrospectively assessed using the clinical global impressions-improvement (CGI-I) by two independent reviewers. Results: One hundred sixty-five patients were hospitalized for catatonia, of whom 50.3% had an NDD. Median age was 15. One hundred sixty-four patients were treated with a benzodiazepine, with a median maximum 24-hour dose of 6 mg lorazepam-equivalents, which did not differ for patients with and without NDDs. Electroconvulsive therapy (ECT) was utilized in 14.5% of patients. Median length of medical hospitalization was 5 days and hospitalizations were longer in neurotypical patients than in patients with NDDs. In an ordinal regression model, the probability of observing at least “much improvement” (CGI < 3) was 88.3% (95% CI: 82.4% to 92.3%), with NDD diagnosis associated with a lower odds of clinical response. Conclusions: The probability of patients achieving a CGI-I score indicating at least “much improvement” was 88.3%. Administered benzodiazepine dose and ECT treatment were similar for all patients, but neurotypical patients had longer hospitalizations than those with NDDs and had a higher odds of a more favorable clinical response. Research under controlled conditions is needed to optimize and endure equitable catatonia treatment in youth.